Dementia With Lewy Bodies Clinical Trials

20 recruiting

Dementia With Lewy Bodies Trials at a Glance

22 actively recruiting trials for dementia with lewy bodies are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Nashville, Strasbourg, and Minneapolis. Lead sponsors running dementia with lewy bodies studies include Georgetown University, University Hospital, Strasbourg, France, and Association de Recherche Bibliographique pour les Neurosciences.

Browse dementia with lewy bodies trials by phase

Treatments under study

About Dementia With Lewy Bodies Clinical Trials

Looking for clinical trials for Dementia With Lewy Bodies? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dementia With Lewy Bodies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dementia With Lewy Bodies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 1

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+2 more
Daniel Claassen40 enrolled1 locationNCT04246437
Recruiting
Phase 4

Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

Dementia With Lewy BodiesParkinson Disease Dementia
Virginia Commonwealth University120 enrolled1 locationNCT07284290
Recruiting
Early Phase 1

PET Imaging Evaluation of [11C]SY08

Multiple System AtrophyDementia With Lewy BodiesParkinson's Disease
Massachusetts General Hospital40 enrolled1 locationNCT06098612
Recruiting
Early Phase 1

[18F]ACI-15916 PET in α-synucleinopathies

Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA46 enrolled1 locationNCT06891703
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting

Exploration of GCase Activity to Identify a Subpopulation Eligible for a Therapeutic Trial in Dementia With Lewy Bodies

Dementia With Lewy Bodies
Assistance Publique - Hôpitaux de Paris236 enrolled1 locationNCT05304195
Recruiting
Not Applicable

tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden

Dementia With Lewy BodiesLewy Body DiseaseLewy Body Dementia+2 more
Association de Recherche Bibliographique pour les Neurosciences30 enrolled1 locationNCT06785948
Recruiting
Phase 4

Comparing Antipsychotic Medications in LBD Over Time

Dementia With Lewy BodiesParkinson's Disease Psychosis
The University of Texas Health Science Center at San Antonio94 enrolled2 locationsNCT05590637
Recruiting
Not Applicable

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

Alzheimer DiseaseDementia With Lewy BodiesFrontotemporal Dementia
Kuopio University Hospital200 enrolled1 locationNCT05326750
Recruiting
Phase 1Phase 2

The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies

Dementia With Lewy Bodies
Korea University Anam Hospital10 enrolled1 locationNCT07122908
Recruiting
Not Applicable

Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) in Cognitive Fluctuations of Dementia With Lewy Bodies (DLB): Proof of Concept

Dementia With Lewy Bodies DiagnosisSignificant Cognitive Fluctuations in DLB
University Hospital, Strasbourg, France40 enrolled1 locationNCT05138588
Recruiting
Not Applicable

Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder

Parkinson DiseaseDementia With Lewy BodiesREM Sleep Behavior Disorder
University of Minnesota60 enrolled1 locationNCT06467461
Recruiting

Natural History Study of Synucleinopathies

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+5 more
NYU Langone Health800 enrolled8 locationsNCT01799915
Recruiting

Optical Neuroimaging and Cognition

Alzheimer DiseaseDementia With Lewy BodiesMild Cognitive Impairment
University of Cambridge200 enrolled1 locationNCT05460143
Recruiting
Not Applicable

PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia

Dementia With Lewy BodiesLewy Body DiseaseLewy Body Dementia+1 more
Rush University Medical Center622 enrolled1 locationNCT06389032
Recruiting
Phase 2Phase 3

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD

Alzheimer DiseaseParkinson DiseaseDementia With Lewy Bodies+1 more
prof. dr. Koen Van Laere113 enrolled2 locationsNCT06120049
Recruiting

North American Prodromal Synucleinopathy Consortium Stage 2

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+3 more
Washington University School of Medicine500 enrolled9 locationsNCT05826457
Recruiting
Phase 2

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies

Dementia With Lewy Bodies
Georgetown University60 enrolled1 locationNCT04002674
Recruiting

Cerebro Spinal Fluid Collection (CSF)

Multiple System AtrophyAlzheimer DiseaseDementia With Lewy Bodies+2 more
University Hospital, Strasbourg, France10,000 enrolled1 locationNCT04844060
Recruiting
Phase 2

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Dementia With Lewy Bodies
Georgetown University45 enrolled1 locationNCT03996460